Moderated by: Nazia Selzner & James Pomposelli

Targeting Tumoral Fatty Acid Desaturase 1 Empower IL-15-Armed GPC3-CAR-T Therapy in Hepatocellular Carcinoma
Tao Ding

Clinical Features and Long-Term Outcomes of Patients with Complete Immunosuppression Withdrawal After Liver Transplantation: A Multicentre, Worldwide Study
Roberta Angelico

Non-Vascular, Non-Cirrhotic Portal Hypertension Following Liver Transplantation Is Largely Caused by Combination of Portosinusoidal Injury and Allograft Rejection
Iulia Minciuna

Auxiliary Partial Orthotopic Liver Transplantation Provides Durable Recovery in Pediatric Fulminant Hepatic Failure: Multicenter Experience in Children <10 Years
Tomoaki Kato

Towards Time-Unlimited Liver Preservation: Key Steps in Advancing Long-Term Ex Vivo Normothermic Machine Perfusion from Days to 7 Weeks
Carlo Pulitano

From National Policy to Clinical Practice: Early Experience with a Structured Prehabilitation and Rehabilitation Pathway in Liver Transplantation
Diethard Monbaliu

Off-the-Shelf CAR-T Cells Resistant to Immunosuppression for Cancer Therapy in Transplant Recipients
Xinyang Zhong